listed · IPO · BSE/NSE · listed 17 August 2026
Molbio Diagnostics Limited
Raised ₹939.85 Cr at ₹807 per share.
+28.4%
listing-day move
Price band
₹768 – ₹807
Issue price
₹807
Issue size
₹939.85 Cr
Listing-day close
₹1,036.3
Return since listing
+43.80%
Company research
Tijori FinanceMolbio Diagnostics Limited, incorporated in 2000, is engaged in developing, manufacturing and commercializing point-of-care molecular diagnostic solutions. The company operates in the healthcare diagnostics segment, offering rapid testing solutions for infectious and non-communicable diseases through its Truenat platform.
Financials — ₹ crore
| Period | Revenue | PAT | Debt |
|---|---|---|---|
| Mar 2024 | 836.56 Cr | 101.95 Cr | 174.58 Cr |
| Mar 2025 | 1,020.42 Cr | 145.1 Cr | 123.16 Cr |
| Mar 2026 | 1,445.69 Cr | 166.59 Cr | 412.64 Cr |
Revenue mix
PCR devices
100%
Peer comparison
Company Mkt cap Revenue P/E P/B
MOLBIO 13,068 1,445 Cr 78.44 11.18
POLYMED 17,930 1,875 Cr 56.91 5.77
LALPATHLAB 32,259 2,762 Cr 59.53 12.86
METROPOLIS 12,283 1,645 Cr 60.92 8.12
VIJAYA 15,511 814 Cr 82.73 16.21
Exchange filings
Fields captured from NSE and BSEIssue information
- Symbol
- MOLBIO
- Issue period
- 2026-08-10 to 2026-08-12
- Price range
- Rs.768 to Rs.807
- Red Herring Prospectus
- https://nsearchives.nseindia.com/corporate/MolbioDiagnosticsLimited_RHP.zip
Documents
Data sources: BSE , BSE , MONEYCONTROL , NSE , YAHOO , NSE . Data quality clean.